1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Short Sleep Syndrome Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Short Sleep Syndrome Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Short Sleep Syndrome Treatment by Country/Region, 2018, 2022 & 2029
2.2 Short Sleep Syndrome Treatment Segment by Type
2.2.1 Benzodiazepines
2.2.2 Nonbenzodiazepines
2.2.3 Antidepressants
2.2.4 Orexin Antagonist
2.2.5 Melatonin Antagonist
2.2.6 Other
2.3 Short Sleep Syndrome Treatment Sales by Type
2.3.1 Global Short Sleep Syndrome Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Short Sleep Syndrome Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Short Sleep Syndrome Treatment Sale Price by Type (2018-2023)
2.4 Short Sleep Syndrome Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Short Sleep Syndrome Treatment Sales by Application
2.5.1 Global Short Sleep Syndrome Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Short Sleep Syndrome Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Short Sleep Syndrome Treatment Sale Price by Application (2018-2023)
3 Global Short Sleep Syndrome Treatment by Company
3.1 Global Short Sleep Syndrome Treatment Breakdown Data by Company
3.1.1 Global Short Sleep Syndrome Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Short Sleep Syndrome Treatment Sales Market Share by Company (2018-2023)
3.2 Global Short Sleep Syndrome Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Short Sleep Syndrome Treatment Revenue by Company (2018-2023)
3.2.2 Global Short Sleep Syndrome Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Short Sleep Syndrome Treatment Sale Price by Company
3.4 Key Manufacturers Short Sleep Syndrome Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Short Sleep Syndrome Treatment Product Location Distribution
3.4.2 Players Short Sleep Syndrome Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Short Sleep Syndrome Treatment by Geographic Region
4.1 World Historic Short Sleep Syndrome Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Short Sleep Syndrome Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Short Sleep Syndrome Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Short Sleep Syndrome Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Short Sleep Syndrome Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Short Sleep Syndrome Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Short Sleep Syndrome Treatment Sales Growth
4.4 APAC Short Sleep Syndrome Treatment Sales Growth
4.5 Europe Short Sleep Syndrome Treatment Sales Growth
4.6 Middle East & Africa Short Sleep Syndrome Treatment Sales Growth
5 Americas
5.1 Americas Short Sleep Syndrome Treatment Sales by Country
5.1.1 Americas Short Sleep Syndrome Treatment Sales by Country (2018-2023)
5.1.2 Americas Short Sleep Syndrome Treatment Revenue by Country (2018-2023)
5.2 Americas Short Sleep Syndrome Treatment Sales by Type
5.3 Americas Short Sleep Syndrome Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Short Sleep Syndrome Treatment Sales by Region
6.1.1 APAC Short Sleep Syndrome Treatment Sales by Region (2018-2023)
6.1.2 APAC Short Sleep Syndrome Treatment Revenue by Region (2018-2023)
6.2 APAC Short Sleep Syndrome Treatment Sales by Type
6.3 APAC Short Sleep Syndrome Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Short Sleep Syndrome Treatment by Country
7.1.1 Europe Short Sleep Syndrome Treatment Sales by Country (2018-2023)
7.1.2 Europe Short Sleep Syndrome Treatment Revenue by Country (2018-2023)
7.2 Europe Short Sleep Syndrome Treatment Sales by Type
7.3 Europe Short Sleep Syndrome Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Short Sleep Syndrome Treatment by Country
8.1.1 Middle East & Africa Short Sleep Syndrome Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Short Sleep Syndrome Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Short Sleep Syndrome Treatment Sales by Type
8.3 Middle East & Africa Short Sleep Syndrome Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Short Sleep Syndrome Treatment
10.3 Manufacturing Process Analysis of Short Sleep Syndrome Treatment
10.4 Industry Chain Structure of Short Sleep Syndrome Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Short Sleep Syndrome Treatment Distributors
11.3 Short Sleep Syndrome Treatment Customer
12 World Forecast Review for Short Sleep Syndrome Treatment by Geographic Region
12.1 Global Short Sleep Syndrome Treatment Market Size Forecast by Region
12.1.1 Global Short Sleep Syndrome Treatment Forecast by Region (2024-2029)
12.1.2 Global Short Sleep Syndrome Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Short Sleep Syndrome Treatment Forecast by Type
12.7 Global Short Sleep Syndrome Treatment Forecast by Application
13 Key Players Analysis
13.1 Merck & co.
13.1.1 Merck & co. Company Information
13.1.2 Merck & co. Short Sleep Syndrome Treatment Product Portfolios and Specifications
13.1.3 Merck & co. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck & co. Main Business Overview
13.1.5 Merck & co. Latest Developments
13.2 Mylan N.V.
13.2.1 Mylan N.V. Company Information
13.2.2 Mylan N.V. Short Sleep Syndrome Treatment Product Portfolios and Specifications
13.2.3 Mylan N.V. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mylan N.V. Main Business Overview
13.2.5 Mylan N.V. Latest Developments
13.3 Paratek pharmaceuticals
13.3.1 Paratek pharmaceuticals Company Information
13.3.2 Paratek pharmaceuticals Short Sleep Syndrome Treatment Product Portfolios and Specifications
13.3.3 Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Paratek pharmaceuticals Main Business Overview
13.3.5 Paratek pharmaceuticals Latest Developments
13.4 Pfizer Inc.
13.4.1 Pfizer Inc. Company Information
13.4.2 Pfizer Inc. Short Sleep Syndrome Treatment Product Portfolios and Specifications
13.4.3 Pfizer Inc. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Inc. Main Business Overview
13.4.5 Pfizer Inc. Latest Developments
13.5 Sanofi S.A.
13.5.1 Sanofi S.A. Company Information
13.5.2 Sanofi S.A. Short Sleep Syndrome Treatment Product Portfolios and Specifications
13.5.3 Sanofi S.A. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi S.A. Main Business Overview
13.5.5 Sanofi S.A. Latest Developments
13.6 Sumitomo Dainippon pharma Co. Ltd.
13.6.1 Sumitomo Dainippon pharma Co. Ltd. Company Information
13.6.2 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product Portfolios and Specifications
13.6.3 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sumitomo Dainippon pharma Co. Ltd. Main Business Overview
13.6.5 Sumitomo Dainippon pharma Co. Ltd. Latest Developments
13.7 Takeda Pharmaceuticals Company Ltd.
13.7.1 Takeda Pharmaceuticals Company Ltd. Company Information
13.7.2 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product Portfolios and Specifications
13.7.3 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Takeda Pharmaceuticals Company Ltd. Main Business Overview
13.7.5 Takeda Pharmaceuticals Company Ltd. Latest Developments
13.8 Teva Pharmaceutical Industries Ltd.
13.8.1 Teva Pharmaceutical Industries Ltd. Company Information
13.8.2 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product Portfolios and Specifications
13.8.3 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.8.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.9 Vanda Pharmaceuticals Inc.
13.9.1 Vanda Pharmaceuticals Inc. Company Information
13.9.2 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product Portfolios and Specifications
13.9.3 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Vanda Pharmaceuticals Inc. Main Business Overview
13.9.5 Vanda Pharmaceuticals Inc. Latest Developments
14 Research Findings and Conclusion
Table 1. Short Sleep Syndrome Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Short Sleep Syndrome Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Benzodiazepines
Table 4. Major Players of Nonbenzodiazepines
Table 5. Major Players of Antidepressants
Table 6. Major Players of Orexin Antagonist
Table 7. Major Players of Melatonin Antagonist
Table 8. Major Players of Other
Table 9. Global Short Sleep Syndrome Treatment Sales by Type (2018-2023) & (K Units)
Table 10. Global Short Sleep Syndrome Treatment Sales Market Share by Type (2018-2023)
Table 11. Global Short Sleep Syndrome Treatment Revenue by Type (2018-2023) & ($ million)
Table 12. Global Short Sleep Syndrome Treatment Revenue Market Share by Type (2018-2023)
Table 13. Global Short Sleep Syndrome Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 14. Global Short Sleep Syndrome Treatment Sales by Application (2018-2023) & (K Units)
Table 15. Global Short Sleep Syndrome Treatment Sales Market Share by Application (2018-2023)
Table 16. Global Short Sleep Syndrome Treatment Revenue by Application (2018-2023)
Table 17. Global Short Sleep Syndrome Treatment Revenue Market Share by Application (2018-2023)
Table 18. Global Short Sleep Syndrome Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 19. Global Short Sleep Syndrome Treatment Sales by Company (2018-2023) & (K Units)
Table 20. Global Short Sleep Syndrome Treatment Sales Market Share by Company (2018-2023)
Table 21. Global Short Sleep Syndrome Treatment Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Short Sleep Syndrome Treatment Revenue Market Share by Company (2018-2023)
Table 23. Global Short Sleep Syndrome Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 24. Key Manufacturers Short Sleep Syndrome Treatment Producing Area Distribution and Sales Area
Table 25. Players Short Sleep Syndrome Treatment Products Offered
Table 26. Short Sleep Syndrome Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Short Sleep Syndrome Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Short Sleep Syndrome Treatment Sales Market Share Geographic Region (2018-2023)
Table 31. Global Short Sleep Syndrome Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Short Sleep Syndrome Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Short Sleep Syndrome Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Short Sleep Syndrome Treatment Sales Market Share by Country/Region (2018-2023)
Table 35. Global Short Sleep Syndrome Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Short Sleep Syndrome Treatment Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Short Sleep Syndrome Treatment Sales by Country (2018-2023) & (K Units)
Table 38. Americas Short Sleep Syndrome Treatment Sales Market Share by Country (2018-2023)
Table 39. Americas Short Sleep Syndrome Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Short Sleep Syndrome Treatment Revenue Market Share by Country (2018-2023)
Table 41. Americas Short Sleep Syndrome Treatment Sales by Type (2018-2023) & (K Units)
Table 42. Americas Short Sleep Syndrome Treatment Sales by Application (2018-2023) & (K Units)
Table 43. APAC Short Sleep Syndrome Treatment Sales by Region (2018-2023) & (K Units)
Table 44. APAC Short Sleep Syndrome Treatment Sales Market Share by Region (2018-2023)
Table 45. APAC Short Sleep Syndrome Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Short Sleep Syndrome Treatment Revenue Market Share by Region (2018-2023)
Table 47. APAC Short Sleep Syndrome Treatment Sales by Type (2018-2023) & (K Units)
Table 48. APAC Short Sleep Syndrome Treatment Sales by Application (2018-2023) & (K Units)
Table 49. Europe Short Sleep Syndrome Treatment Sales by Country (2018-2023) & (K Units)
Table 50. Europe Short Sleep Syndrome Treatment Sales Market Share by Country (2018-2023)
Table 51. Europe Short Sleep Syndrome Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Short Sleep Syndrome Treatment Revenue Market Share by Country (2018-2023)
Table 53. Europe Short Sleep Syndrome Treatment Sales by Type (2018-2023) & (K Units)
Table 54. Europe Short Sleep Syndrome Treatment Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Short Sleep Syndrome Treatment Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Short Sleep Syndrome Treatment Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Short Sleep Syndrome Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Short Sleep Syndrome Treatment Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Short Sleep Syndrome Treatment Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Short Sleep Syndrome Treatment Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Short Sleep Syndrome Treatment
Table 62. Key Market Challenges & Risks of Short Sleep Syndrome Treatment
Table 63. Key Industry Trends of Short Sleep Syndrome Treatment
Table 64. Short Sleep Syndrome Treatment Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Short Sleep Syndrome Treatment Distributors List
Table 67. Short Sleep Syndrome Treatment Customer List
Table 68. Global Short Sleep Syndrome Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Short Sleep Syndrome Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Short Sleep Syndrome Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Short Sleep Syndrome Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Short Sleep Syndrome Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Short Sleep Syndrome Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Short Sleep Syndrome Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Short Sleep Syndrome Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Short Sleep Syndrome Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Short Sleep Syndrome Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Short Sleep Syndrome Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Short Sleep Syndrome Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Short Sleep Syndrome Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Short Sleep Syndrome Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Merck & co. Basic Information, Short Sleep Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck & co. Short Sleep Syndrome Treatment Product Portfolios and Specifications
Table 84. Merck & co. Short Sleep Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Merck & co. Main Business
Table 86. Merck & co. Latest Developments
Table 87. Mylan N.V. Basic Information, Short Sleep Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 88. Mylan N.V. Short Sleep Syndrome Treatment Product Portfolios and Specifications
Table 89. Mylan N.V. Short Sleep Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Mylan N.V. Main Business
Table 91. Mylan N.V. Latest Developments
Table 92. Paratek pharmaceuticals Basic Information, Short Sleep Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 93. Paratek pharmaceuticals Short Sleep Syndrome Treatment Product Portfolios and Specifications
Table 94. Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Paratek pharmaceuticals Main Business
Table 96. Paratek pharmaceuticals Latest Developments
Table 97. Pfizer Inc. Basic Information, Short Sleep Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Inc. Short Sleep Syndrome Treatment Product Portfolios and Specifications
Table 99. Pfizer Inc. Short Sleep Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Pfizer Inc. Main Business
Table 101. Pfizer Inc. Latest Developments
Table 102. Sanofi S.A. Basic Information, Short Sleep Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi S.A. Short Sleep Syndrome Treatment Product Portfolios and Specifications
Table 104. Sanofi S.A. Short Sleep Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Sanofi S.A. Main Business
Table 106. Sanofi S.A. Latest Developments
Table 107. Sumitomo Dainippon pharma Co. Ltd. Basic Information, Short Sleep Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 108. Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product Portfolios and Specifications
Table 109. Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Sumitomo Dainippon pharma Co. Ltd. Main Business
Table 111. Sumitomo Dainippon pharma Co. Ltd. Latest Developments
Table 112. Takeda Pharmaceuticals Company Ltd. Basic Information, Short Sleep Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 113. Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product Portfolios and Specifications
Table 114. Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Takeda Pharmaceuticals Company Ltd. Main Business
Table 116. Takeda Pharmaceuticals Company Ltd. Latest Developments
Table 117. Teva Pharmaceutical Industries Ltd. Basic Information, Short Sleep Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 118. Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product Portfolios and Specifications
Table 119. Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Teva Pharmaceutical Industries Ltd. Main Business
Table 121. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 122. Vanda Pharmaceuticals Inc. Basic Information, Short Sleep Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 123. Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product Portfolios and Specifications
Table 124. Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Vanda Pharmaceuticals Inc. Main Business
Table 126. Vanda Pharmaceuticals Inc. Latest Developments
List of Figures
Figure 1. Picture of Short Sleep Syndrome Treatment
Figure 2. Short Sleep Syndrome Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Short Sleep Syndrome Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Short Sleep Syndrome Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Short Sleep Syndrome Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Benzodiazepines
Figure 10. Product Picture of Nonbenzodiazepines
Figure 11. Product Picture of Antidepressants
Figure 12. Product Picture of Orexin Antagonist
Figure 13. Product Picture of Melatonin Antagonist
Figure 14. Product Picture of Other
Figure 15. Global Short Sleep Syndrome Treatment Sales Market Share by Type in 2022
Figure 16. Global Short Sleep Syndrome Treatment Revenue Market Share by Type (2018-2023)
Figure 17. Short Sleep Syndrome Treatment Consumed in Hospital Pharmacies
Figure 18. Global Short Sleep Syndrome Treatment Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 19. Short Sleep Syndrome Treatment Consumed in Retail Pharmacies
Figure 20. Global Short Sleep Syndrome Treatment Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 21. Short Sleep Syndrome Treatment Consumed in Online Pharmacies
Figure 22. Global Short Sleep Syndrome Treatment Market: Online Pharmacies (2018-2023) & (K Units)
Figure 23. Global Short Sleep Syndrome Treatment Sales Market Share by Application (2022)
Figure 24. Global Short Sleep Syndrome Treatment Revenue Market Share by Application in 2022
Figure 25. Short Sleep Syndrome Treatment Sales Market by Company in 2022 (K Units)
Figure 26. Global Short Sleep Syndrome Treatment Sales Market Share by Company in 2022
Figure 27. Short Sleep Syndrome Treatment Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Short Sleep Syndrome Treatment Revenue Market Share by Company in 2022
Figure 29. Global Short Sleep Syndrome Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Short Sleep Syndrome Treatment Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Short Sleep Syndrome Treatment Sales 2018-2023 (K Units)
Figure 32. Americas Short Sleep Syndrome Treatment Revenue 2018-2023 ($ Millions)
Figure 33. APAC Short Sleep Syndrome Treatment Sales 2018-2023 (K Units)
Figure 34. APAC Short Sleep Syndrome Treatment Revenue 2018-2023 ($ Millions)
Figure 35. Europe Short Sleep Syndrome Treatment Sales 2018-2023 (K Units)
Figure 36. Europe Short Sleep Syndrome Treatment Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Short Sleep Syndrome Treatment Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Short Sleep Syndrome Treatment Revenue 2018-2023 ($ Millions)
Figure 39. Americas Short Sleep Syndrome Treatment Sales Market Share by Country in 2022
Figure 40. Americas Short Sleep Syndrome Treatment Revenue Market Share by Country in 2022
Figure 41. Americas Short Sleep Syndrome Treatment Sales Market Share by Type (2018-2023)
Figure 42. Americas Short Sleep Syndrome Treatment Sales Market Share by Application (2018-2023)
Figure 43. United States Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Short Sleep Syndrome Treatment Sales Market Share by Region in 2022
Figure 48. APAC Short Sleep Syndrome Treatment Revenue Market Share by Regions in 2022
Figure 49. APAC Short Sleep Syndrome Treatment Sales Market Share by Type (2018-2023)
Figure 50. APAC Short Sleep Syndrome Treatment Sales Market Share by Application (2018-2023)
Figure 51. China Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Short Sleep Syndrome Treatment Sales Market Share by Country in 2022
Figure 59. Europe Short Sleep Syndrome Treatment Revenue Market Share by Country in 2022
Figure 60. Europe Short Sleep Syndrome Treatment Sales Market Share by Type (2018-2023)
Figure 61. Europe Short Sleep Syndrome Treatment Sales Market Share by Application (2018-2023)
Figure 62. Germany Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Short Sleep Syndrome Treatment Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Short Sleep Syndrome Treatment Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Short Sleep Syndrome Treatment Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Short Sleep Syndrome Treatment Sales Market Share by Application (2018-2023)
Figure 71. Egypt Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Short Sleep Syndrome Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Short Sleep Syndrome Treatment in 2022
Figure 77. Manufacturing Process Analysis of Short Sleep Syndrome Treatment
Figure 78. Industry Chain Structure of Short Sleep Syndrome Treatment
Figure 79. Channels of Distribution
Figure 80. Global Short Sleep Syndrome Treatment Sales Market Forecast by Region (2024-2029)
Figure 81. Global Short Sleep Syndrome Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Short Sleep Syndrome Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Short Sleep Syndrome Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Short Sleep Syndrome Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Short Sleep Syndrome Treatment Revenue Market Share Forecast by Application (2024-2029)